Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Introduction: It remains unclear which surgery or radiofrequency ablation (RFA) is the more
effective treatment for small hepatocellular carcinoma (HCC). We aimed to compare survival …

Primary liver cancer—including hepatocellular carcinoma (HCC) and intrahepatic
cholangiocarcinoma (ICC)—incidence is increasing and is an important source of cancer …

Background Hepatic resection and radiofrequency ablation (RFA) are treatment options for
early-stage hepatocellular carcinoma (HCC). Whether tumour recurrence and long-term …

Purpose To compare the benefits and harms of radiofrequency ablation (RFA) and hepatic
resection (HR) and to test the consistency of currently available evidence. Materials and …

Background and purpose Stereotactic body radiotherapy (SBRT) is an emerging ablative
modality for hepatocellular carcinoma (HCC). This study aimed to synthesize available …

Background & Aims The role of hepatic resection for hepatocellular carcinoma (HCC) in
different Barcelona Clinic Liver Cancer (BCLC) stages is controversial. We aimed at …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Hepatocellular carcinoma (HCC), in its very early stage, is heterogeneous both in terms of
liver function (ie, presence or absence of portal hypertension, model for end-stage liver …